{"title":"免疫介导的脑炎。","authors":"","doi":"10.1111/dmcn.16029","DOIUrl":null,"url":null,"abstract":"<p>A neurological deterioration in a child is both a significant worry to the family and a challenge to the doctor making a diagnosis. We are recognising that the immune system, which plays an important role in protecting and maintaining the brain and body, can contribute to brain disease in children when it becomes unregulated. Sometimes infection itself can trigger inflammation. It is important to work out the underlying cause of this inflammation.</p><p>Magnetic resonance imaging plays an important role. However, this can be normal in a proportion of children with brain inflammation, and other types of scans are now being researched but are not yet ready for clinical practice. Fluid around the brain and spine may show evidence of immune upregulation with cells or raised protein, but may also be normal. Careful measurement of chemicals released during inflammation may offer more clues, alongside measuring very specific components of the immune system like proteins that target the body called antibodies. It is important to interpret these tests carefully as they can be found even when there is no disease. Clinicians need to match these findings with how the patients present. Using these methods, researchers have started to recognize new conditions like myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and another called virus-associated encephalopathy syndromes.</p><p>It is important to recognize these conditions to be able to begin to treat them. Treatments for neuroinflammation are aimed to promote recovery, and preventing the illness recurring. Furthermore, there is a move towards increasing treatment quickly if children fail to respond adequately. Clinicians and researchers are striving to create treatments targeted to the particular immune response in an individual child.</p>","PeriodicalId":50587,"journal":{"name":"Developmental Medicine and Child Neurology","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dmcn.16029","citationCount":"0","resultStr":"{\"title\":\"Immune-mediated encephalitis\",\"authors\":\"\",\"doi\":\"10.1111/dmcn.16029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A neurological deterioration in a child is both a significant worry to the family and a challenge to the doctor making a diagnosis. We are recognising that the immune system, which plays an important role in protecting and maintaining the brain and body, can contribute to brain disease in children when it becomes unregulated. Sometimes infection itself can trigger inflammation. It is important to work out the underlying cause of this inflammation.</p><p>Magnetic resonance imaging plays an important role. However, this can be normal in a proportion of children with brain inflammation, and other types of scans are now being researched but are not yet ready for clinical practice. Fluid around the brain and spine may show evidence of immune upregulation with cells or raised protein, but may also be normal. Careful measurement of chemicals released during inflammation may offer more clues, alongside measuring very specific components of the immune system like proteins that target the body called antibodies. It is important to interpret these tests carefully as they can be found even when there is no disease. Clinicians need to match these findings with how the patients present. Using these methods, researchers have started to recognize new conditions like myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and another called virus-associated encephalopathy syndromes.</p><p>It is important to recognize these conditions to be able to begin to treat them. Treatments for neuroinflammation are aimed to promote recovery, and preventing the illness recurring. Furthermore, there is a move towards increasing treatment quickly if children fail to respond adequately. Clinicians and researchers are striving to create treatments targeted to the particular immune response in an individual child.</p>\",\"PeriodicalId\":50587,\"journal\":{\"name\":\"Developmental Medicine and Child Neurology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dmcn.16029\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developmental Medicine and Child Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16029\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Medicine and Child Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16029","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
A neurological deterioration in a child is both a significant worry to the family and a challenge to the doctor making a diagnosis. We are recognising that the immune system, which plays an important role in protecting and maintaining the brain and body, can contribute to brain disease in children when it becomes unregulated. Sometimes infection itself can trigger inflammation. It is important to work out the underlying cause of this inflammation.
Magnetic resonance imaging plays an important role. However, this can be normal in a proportion of children with brain inflammation, and other types of scans are now being researched but are not yet ready for clinical practice. Fluid around the brain and spine may show evidence of immune upregulation with cells or raised protein, but may also be normal. Careful measurement of chemicals released during inflammation may offer more clues, alongside measuring very specific components of the immune system like proteins that target the body called antibodies. It is important to interpret these tests carefully as they can be found even when there is no disease. Clinicians need to match these findings with how the patients present. Using these methods, researchers have started to recognize new conditions like myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and another called virus-associated encephalopathy syndromes.
It is important to recognize these conditions to be able to begin to treat them. Treatments for neuroinflammation are aimed to promote recovery, and preventing the illness recurring. Furthermore, there is a move towards increasing treatment quickly if children fail to respond adequately. Clinicians and researchers are striving to create treatments targeted to the particular immune response in an individual child.
期刊介绍:
Wiley-Blackwell is pleased to publish Developmental Medicine & Child Neurology (DMCN), a Mac Keith Press publication and official journal of the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) and the British Paediatric Neurology Association (BPNA).
For over 50 years, DMCN has defined the field of paediatric neurology and neurodisability and is one of the world’s leading journals in the whole field of paediatrics. DMCN disseminates a range of information worldwide to improve the lives of disabled children and their families. The high quality of published articles is maintained by expert review, including independent statistical assessment, before acceptance.